Lv4
580 积分 2023-12-10 加入
Corrigendum to “Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death”: [Modern Pathology 36 (2023) 100085]
3天前
已完结
Corrigendum to “Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death”: [Modern Pathology 36 (2023) 100085]
8天前
已完结
GALLANT: A phase 2 study using metronomic gemcitabine, doxorubicin, nivolumab, and docetaxel as second/third-line therapy for advanced sarcoma (NCT04535713)
19天前
已完结
Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death
19天前
已完结
Mechanistic diversity in ATP-binding cassette (ABC) transporters
19天前
已完结
A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
19天前
已完结
CircRNA–miRNA networks in regulating bone disease
19天前
已完结
Cell Cycle Kinases in Osteosarcoma: Potential for Therapeutic Intervention
20天前
已完结
Novel Immunotherapies for Osteosarcoma
20天前
已完结
Multiple roles of HOX proteins in Metastasis: Let me count the ways
25天前
已完结
皖公网安备34019202002308
